Curated by Fabrice Gribon, founder and CEO of Gribon & Company
The CEO Shortlist – practical insight on operational performance and execution
A persistent operational bottleneck continues to quietly drain capacity on sterile filling lines across the UK and Ireland. While site leaders focus on physical line speed, the administrative "hidden factory" of manual documentation review remains a primary driver of release delays. The core issue is not a simple capacity deficit, but rather a deeply ingrained regulatory conservatism and a cultural training gap that treats documentation as an administrative afterthought rather than an intrinsic step of the manufacturing process.
By addressing the systemic misinterpretation of compliance mandates and re-aligning operator ownership, sites can reclaim lost capacity without inflating overheads. This shift directly enhances manufacturing stability, secures patient supply, and improves financial performance sustainably.
Why do highly regulated aseptic manufacturing sites still lose significant operational momentum to retrospective paperwork loops?
Operations leaders navigate a highly constrained environment where ensuring reliable patient supply is paramount. Yet, our diagnostic work in early 2026 across sterile facilities in the UK and Ireland revealed a costly, recurring pattern: teams spending 12 to 18 hours per week reviewing single batch records. During our engagement at a mid-sized commercial biologics fill-finish facility, this friction manifested as a 9-day average release hold waiting solely on missing in-process signatures. At a neighbouring clinical manufacturing site, teams logged 14 hours per week purely on administrative rework comments. These delays are driven by a fundamental misunderstanding: treating compliance as a retrospective QA policing exercise rather than an operational discipline.
The fundamental misstep most organisations make is treating batch record delays as a resource capacity problem to be solved by adding QA headcount—an expensive economic trade-off that yields diminishing returns. In reality, the loss is driven by three distinct structural barriers:
In our analysis of 28 sampled aseptic batch records at a UK sterile facility, 54% of all documented review comments stemmed from this exact type of preventable administrative cascade, locking highly paid QA specialists into low-value clerical chasing.
To unlock latent capacity and stabilise release cycles, site heads must dismantle the regulatory myths and realign operational ownership. In a recent pilot across three critical sterile filling lines, transitioning to concurrent verification and clarifying regulatory expectations reduced average review time from 16 hours per week to just 7.5 hours in only five weeks.
We recommend three immediate interventions:
1. De-risk concurrent review with QA: Re-interpret regulatory guidelines to allow QA and shift leads to perform real-time verification at the end of each unit operation, rather than waiting for final batch closure.
2. Integrate documentation into standard work: Redesign operator training so that completing a record is treated as a critical process parameter (CPP) equivalent to sterile interventions, preventing the signature cascade before it starts.
3. Optimise QA resource allocation: Shift QA personnel from retrospective administrative chasing to active, floor-based operational coaching during runs, maximising the economic value of your technical headcount.
Continuing to tolerate these paperwork loops is a choice to misallocate scarce technical resources.
As a site leader, are you content to let defensive regulatory interpretations and a cultural training gap lock your highest-paid QA assets into the role of administrative clerks? Or is it time to treat documentation as a core operational discipline?